share_log

GeneDx to Participate in Upcoming Investor Conference

GeneDx to Participate in Upcoming Investor Conference

GeneDx将参加即将举行的投资者会议
GeneDx Holdings ·  2024/11/22 13:00

STAMFORD, Conn.--(BUSINESS WIRE)--Nov. 22, 2024--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET.

康涅狄格州斯坦福--(商业线)--2024年11月22日--GeneDx(纳斯达克:WGS),通过基因组洞察提供改善健康结果的领先者,今天宣布公司管理层将参加派杰投资第36届医疗保健年会,地点为纽约市,纽约州,时间为2024年12月3日至5日。管理层将于2024年12月3日星期二下午1:00参与火炉聊天。

Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

现场直播和存档网络广播将在GeneDx投资者关系网站ir.genedx.com/news-events/events的"活动"部分提供。

About GeneDx

关于GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

在GeneDx(纳斯达克:WGS),我们相信每个人都应该获得个性化、有针对性的医疗保健,而这一切始于基因诊断。凭借世界上最大的罕见疾病数据集之一,我们领先行业的外显子组和基因组检测将复杂的基因组数据转化为临床答案,解锁个性化健康计划,加速药物研发并提高卫生系统效率。如需更多信息,请访问genedx.com,并在领英、X、Facebook和Instagram上与我们联系。

View source version on businesswire.com:

在businesswire.com上查看源版本:

Investor Relations:
investors@GeneDx.com

投资者关系:
investors@GeneDx.com

Media:
press@GeneDx.com

媒体:
press@GeneDx.com

Source: GeneDx

来源:GeneDx

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发